Caduceus Software Systems Corp. (CSOC) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $1.14M is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerCaduceus Software Systems Corp. (CSOC) trades at $0.003. Caduceus Software Systems Corp. operates in the healthcare technology sector, focusing on software solutions. Market cap: $1.14M, Sector: Healthcare.
Price as of Sep 10, 2026 · Last analyzed: Jun 15, 2026Analyst Coverage for CSOC: CSOC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CSOC against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
These figures come from statements filed 12 months ago — the most recent this company has published.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
CSOC: 1/2 scored disciplines lean bearish. Dominant signal: Izzy Englander bearish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Caduceus Software Systems Corp. (CSOC) Healthcare & Pipeline Overview
Caduceus Software Systems Corp. is a niche player in the healthcare technology sector, leveraging software solutions while also engaging in the pet food industry through its subsidiary, McLovin's Pet Food, Inc., showcasing a diverse product portfolio.
What Is the Investment Thesis for CSOC?
Caduceus Software Systems Corp. presents a unique investment thesis characterized by its dual focus on healthcare technology and the pet care industry. The company's market capitalization stands at approximately $1.11 million, indicating a very small market presence. However, the increasing demand for digital solutions in healthcare represents a significant growth catalyst. The healthcare information services market is projected to grow at a CAGR of 15% over the next five years, providing Caduceus with the opportunity to capture market share if it successfully develops its software solutions. Despite these opportunities, the company faces risks, including a substantial negative profit margin and the challenges associated with operating on the OTC market, which may limit access to capital and increase volatility. Investors should closely monitor the company's operational performance and strategic initiatives in both sectors to gauge its potential for future growth.
Based on FMP financials and quantitative analysis
CSOC Key Highlights
Market capitalization of approximately $1.11 million, indicating a very small market presence.
- Profit margin of -57.5%, highlighting significant financial challenges.
- Gross margin of 23.3%, suggesting potential for operational improvements.
- Beta of -0.40, indicating lower volatility compared to the broader market.
- No dividend yield, reflecting the company's reinvestment strategy or financial constraints.
Who Are CSOC's Competitors?
CSOC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| HIMX Himax Technologies, Inc. | $13.78 | -1.22% | $2.40B | 525-pillar |
| VTVT vTv Therapeutics Inc. | $32.40 | +1.69% | $84.8M | 375-pillar |
| MGRX Mangoceuticals, Inc. | $0.39 | +1.51% | $6.63M | — |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.49 | -1.32% | $9.00M | — |
| BBLN Babylon Holdings Limited | $0.55 | -13.99% | $14.1M | — |
| SCNX Scienture Holdings, Inc. | $0.36 | -2.62% | $14.5M | — |
| BEAT HeartBeam, Inc. | $0.42 | -0.93% | $23.1M | — |
| EUDA EUDA Health Holdings Limited | $13.12 | +0.15% | $24.5M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CSOC's Key Strengths?
Diverse product offerings across pet care and healthcare technology.
- Established subsidiary with brand recognition in the pet food industry.
- Potential for growth in both sectors due to increasing market demand.
- Ability to innovate and adapt to changing consumer preferences.
What Are CSOC's Weaknesses?
Negative profit margin indicating financial instability.
- Very small market capitalization limiting access to capital.
- Challenges associated with operating on the OTC market.
- Limited brand presence outside the pet care sector.
What Could Drive CSOC Stock Higher?
Development of new software solutions aimed at healthcare providers.
- Expansion of product offerings within the pet care industry.
- Strategic partnerships to enhance market reach and distribution.
- Launch of marketing campaigns to promote premium pet products.
- Monitoring of industry trends to adapt product strategies.
What Are the Key Risks for CSOC?
Financial-distress signal — its Altman Z-Score of -6.64 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Continued negative profit margins affecting financial stability.
- Challenges associated with operating on the OTC market.
- Regulatory hurdles in the healthcare technology sector.
- Intense competition from established players in both industries.
What Are the Growth Opportunities for CSOC?
- Growth opportunity 1: The healthcare technology sector is projected to grow at a CAGR of 15% over the next five years, driven by the increasing adoption of digital health solutions. Caduceus Software Systems Corp. can leverage its existing capabilities to develop software solutions that cater to this growing demand, potentially increasing its market share and revenue streams.
- Caduceus, through its subsidiary McLovin's Pet Food, Inc., can expand its product offerings and tap into this lucrative market segment, enhancing its overall revenue.
- Growth opportunity 3: The trend towards premium pet food products is gaining traction, as consumers increasingly seek high-quality and nutritious options for their pets. Caduceus can capitalize on this trend by developing and marketing premium product lines, which may lead to higher profit margins and improved brand loyalty.
- Growth opportunity 4: Strategic partnerships with veterinary clinics and pet care providers could enhance Caduceus's distribution channels and market reach. By collaborating with established players in the pet care industry, the company can increase its visibility and access to a broader customer base.
- Growth opportunity 5: The integration of technology in pet care, such as health monitoring apps and digital pet services, presents an opportunity for Caduceus to innovate its product offerings. By developing tech-driven solutions, the company can attract tech-savvy pet owners and differentiate itself in a competitive market.
What Threats Does CSOC Face?
- Intense competition in both the healthcare and pet care sectors.
- Market volatility associated with OTC trading.
- Regulatory challenges in healthcare technology.
- Economic downturns affecting consumer spending on non-essential items.
What Are CSOC's Competitive Advantages?
- Diverse product portfolio that caters to multiple market segments.
- Established brand recognition through its subsidiary, McLovin's Pet Food, Inc.
- Potential for innovation in both healthcare technology and pet care sectors.
- Ability to leverage technology to enhance product offerings and customer engagement.
- Strategic positioning within the growing pet care and healthcare markets.
What Does CSOC Do?
Caduceus Software Systems Corp., established in 2006, initially operated under the name Bosco Holdings Inc. before rebranding in March 2011. The company is headquartered in Chino, California, and primarily operates through its subsidiary, McLovin's Pet Food, Inc. Caduceus Software Systems Corp. has a diverse product portfolio that includes not only pet food but also hygiene essentials, toys, and various accessories for pet care. This diversification allows the company to tap into multiple revenue streams within the pet care industry. The rebranding to Caduceus Software Systems Corp. reflects a strategic shift towards integrating healthcare technology solutions alongside its existing pet care offerings. While the company has faced challenges, including a negative profit margin of -57.5%, it remains committed to enhancing its product offerings and exploring opportunities within the healthcare technology sector. The growing demand for digital solutions in healthcare presents a potential growth avenue for the company, which aims to leverage its existing capabilities to meet emerging market needs. As of now, Caduceus Software Systems Corp. is positioned to capitalize on trends in both the pet care and healthcare technology industries, although it must navigate significant financial hurdles to achieve sustained profitability.
What Products and Services Does CSOC Offer?
- Operate within the healthcare technology sector, focusing on software solutions.
- Engage in the pet food and care industry through its subsidiary, McLovin's Pet Food, Inc.
- Offer a comprehensive product portfolio, including pet food, hygiene essentials, toys, and accessories.
- Develop and market digital solutions aimed at improving healthcare delivery.
- Leverage technology to enhance product offerings and operational efficiency.
- Focus on meeting the growing demand for quality pet care products and services.
How Does CSOC Make Money?
- Generate revenue through the sale of pet food and care products.
- Develop and sell software solutions for healthcare applications.
- Explore partnerships and collaborations for expanded market reach.
- Capitalize on trends in both the pet care and healthcare technology sectors.
- Invest in product development to enhance competitive positioning.
What Industry Does CSOC Operate In?
The healthcare information services industry is experiencing rapid growth, driven by the increasing need for digital solutions and data management in healthcare settings. The market is projected to grow at a CAGR of 15%, fueled by advancements in technology and the rising demand for efficient healthcare delivery systems. Caduceus Software Systems Corp. operates within this dynamic landscape, positioning itself to capitalize on the growing trend towards digitalization in healthcare. Additionally, the pet care industry is also expanding, with a projected market size of $269 billion by 2025, creating a competitive environment where companies like Caduceus must innovate to maintain market relevance.
Who Are CSOC's Key Customers?
- Pet owners seeking high-quality food and care products for their pets.
- Veterinary clinics and pet care providers looking for reliable product suppliers.
- Healthcare institutions in need of digital solutions for operational efficiency.
- Retailers and distributors within the pet care industry.
- Consumers interested in innovative and premium pet care products.
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 73 days ago
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 45 |
| 2026-08-26 | 45 |
| 2026-08-29 | 45 |
| 2026-09-01 | 45 |
| 2026-09-04 | 45 |
| 2026-09-07 | 45 |
| 2026-09-10 | 45 |
What changed?
The score has stayed at 45.
Over the same 18 days the stock moved +0.7%.
Company Profile
Caduceus Software Systems Corp. operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Chino, US. The company is led by CEO David Ji. CSOC has traded publicly since 2008.
Key Financial Metrics
Return on assets is -23.2%, showing how much profit it generates from its asset base. A current ratio of 0.99 means current liabilities exceed short-term assets, a liquidity point worth watching.
CSOC Valuation & Market Position
With a $1.14M market cap, Caduceus Software Systems Corp. sits in the micro-cap segment of the market.
Quarterly Financial Performance: Caduceus Software Systems Corp.
Revenue for Caduceus Software Systems Corp. came in at $1.1M during Q1 FY2027, a 17.5% contraction versus the preceding quarter. The company recorded a net loss of $1.5M, with diluted EPS of $-0.00. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Healthcare stock should monitor closely. Across the four most recent quarters, CSOC averaged $-0.00 in diluted EPS.
Financial Health
Caduceus Software Systems Corp.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -6.64 places it in the distress zone, a signal of elevated financial risk.
CSOC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Diverse product offerings across pet care and healthcare technology.
- Established subsidiary with brand recognition in the pet food industry.
- Potential for growth in both sectors due to increasing market demand.
- Ability to innovate and adapt to changing consumer preferences.
Bear Case
- Negative profit margin indicating financial instability.
- Very small market capitalization limiting access to capital.
- Challenges associated with operating on the OTC market.
- Limited brand presence outside the pet care sector.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 FY2027 | $1M | -$1M | -$0.0039 |
| Q4 FY2026 | $1M | -$1M | -$0.0032 |
| Q3 FY2026 | $2M | -$49,472 | -$0.0001 |
| Q2 FY2026 | $2M | -$923,713 | -$0.0024 |
Q1 FY2027 · filed 30 Jun 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis
CSOC Latest News
-
Stocks That Hit 52-Week Highs On Tuesday
· Feb 4, 2020
-
Stocks That Hit 52-Week Highs On Monday
· Feb 3, 2020
CSOC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CSOC.
Price Targets
Wall Street price target analysis for CSOC.
CSOC MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CSOC; grades run from A+ (80-100) to F (below 30).
Leadership: David Ji
CEO
David Ji has a robust background in business management and technology, having held various leadership roles in both the healthcare and consumer goods sectors. His experience spans over a decade, during which he has successfully navigated complex market environments and led teams towards achieving strategic objectives. Ji holds a degree in Business Administration and has a keen interest in leveraging technology to drive business growth.
Track Record: Under David Ji's leadership, Caduceus Software Systems Corp. has focused on diversifying its product offerings and exploring new market opportunities. His strategic vision has aimed to align the company's goals with emerging trends in healthcare technology and pet care, although the company continues to face significant financial challenges.
CSOC OTC Market Information
The OTC Other tier represents stocks that do not meet the requirements for higher tiers like NYSE or NASDAQ. Companies in this tier may have limited financial reporting and lower trading volumes, which can lead to higher volatility and risk for investors. This tier often includes smaller companies that are still establishing their market presence.
- OTC Tier: OTC Other
- Limited financial reporting and transparency due to OTC classification.
- Higher volatility and trading risks associated with the OTC market.
- Potential for low liquidity impacting the ability to buy or sell shares.
- Regulatory scrutiny and compliance challenges in the healthcare sector.
- Review the company's latest financial filings and reports.
- Assess the competitive landscape and market positioning.
- Evaluate the management team's experience and track record.
- Monitor industry trends and growth opportunities.
- Investigate any legal or regulatory issues affecting the company.
- Established brand presence through its subsidiary, McLovin's Pet Food, Inc.
- Active engagement in the pet care and healthcare sectors.
- Potential for innovation in product offerings and technology solutions.
Common Questions About CSOC (Healthcare)
Is CSOC a good stock?
Stock Expert AI does not rate CSOC buy, sell or hold. Caduceus Software Systems Corp. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What are the main risks for CSOC?
Caduceus Software Systems Corp. faces several risks, including significant financial challenges as indicated by a negative profit margin of -57.5%. The company operates on the OTC market, which can lead to higher volatility and liquidity issues.
What are the key factors to evaluate for CSOC?
Evaluate CSOC on fundamentals, analyst consensus, and risk factors. Caduceus Software Systems Corp. presents a unique investment thesis characterized by its dual focus on healthcare technology and the pet care industry. Not financial advice.
How frequently does CSOC data refresh on this page?
CSOC's price was last updated on Sep 10, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven CSOC's recent stock price performance?
Caduceus Software Systems Corp. (CSOC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product offerings across pet care and healthcare technology. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CSOC overvalued or undervalued right now?
Caduceus Software Systems Corp. (CSOC) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of CSOC?
Yes, most major brokerages offer fractional shares of Caduceus Software Systems Corp. (CSOC) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track CSOC's earnings and financial reports?
Caduceus Software Systems Corp. (CSOC) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for CSOC earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial reporting and transparency are limited due to OTC classification.